BSECompany Update3 Nov 2026 · 3 Nov 2026, 03:35 pm

Audio recording of Earning/ Quarterly Conference Call

Akums Drugs and Pharmaceuticals Ltd · 544222

✦ AI SummaryResults

Akums Drugs and Pharmaceuticals Ltd has announced the audio recording of its quarterly conference call for the un-audited financial results for the quarter and half year ended on September 30, 2026. The link to the audio recording is provided, and the transcript will be shared with stock exchanges and uploaded on the company's website.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Akums Drugs and Pharmaceuticals Ltd - 544222 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Attachments (1)

📄

69453ee3-6679-4ebe-a137-fdbad487c405.pdf

pdf

Download →
View document text
Ref: Akums/Exchange/2026-27/63 November 03, 2026 To, To, The Listing Department The Listing Department National Stock Exchange of India Ltd. BSE Limited Exchange Plaza, C-1, Block G, 25th Floor, New Trading Ring, Bandra Kurla Complex, Rotunda Building, Phiroze Jeejeebhoy Bandra (E), Mumbai – 400 051 Towers, Dalal Street, Mumbai – 400 001 Symbol: AKUMS Scrip Code: 544222 Sub: Audio recording of Earning/ Quarterly Conference Call held on the un-audited financial results for the quarter and half year ended on September 30, 2026 Respected Sir/Ma’am, Pursuant to the Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below the link of audio recording of Earning/ Quarterly Conference Call held today i.e. Tuesday, November 03, 2026 at 12:00 PM (IST) on the un-audited financial results of Akums Drugs and Pharmaceuticals Limited (“the Company”) for the quarter and half year ended on September 30, 2026. Link: https://www.akums.in/wp-content/uploads/2026/11/Q2-FY27-Audio-Recording.mp3 The transcript for the said call will be shared with the Stock Exchanges and will also be uploaded on the Company’s website at https://www.akums.in/investors/investors-meet/ in due course. This is for your kind information and record. Thanking You Yours Faithfully For Akums Drugs and Pharmaceuticals Limited Dharamvir Malik Company Secretary & Compliance Officer